Related Topics News -

     
 Title only   |   Print 
     
歐康維視降眼壓新藥OT-301上市申請獲受理

2026-09-11T  
歐康維視生物OT-211 III期臨床試驗完成患者入組

2026-09-03T  
歐康維視生物:OT-802 III期臨床試驗完成首例患者入組

2026-05-28T  
歐康維視生物OT-211 III期臨床試驗完成首例患者入組

2026-03-31T  
《業績》歐康維視全年虧損收窄至1.59億人幣 不派息

2026-03-27T  
歐康維視生物玻璃體植入劑ILUVIEN於海南完成患者入組

2026-01-20T  
博安生物阿柏西普眼內注射溶液在中國獲批上市

2025-11-26T  
歐康維視生物OT-702眼內注射溶液獲批在內地上市

2025-11-26T  
《大行》中金料港股通納入20隻股票 包括中國食品曹操出行周六福碧桂園等

2025-08-26T  
歐康維視生物OT-301第二項III期臨床試驗達主要終點

2025-08-21T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.